幾度澄清合併傳聞 中信建投、中信證券攜手下跌
格隆匯8月11日丨A股今日尾盤跳水,三大指數均跌超1%。券商股尾盤大跳水,中信建投收跌7.07%,中信證券收跌5.72%,領跌券商板塊;港股中信建投收跌5.3%,中信證券收跌1.48%。中信證券的市值重新高於中信建投。繼此前幾度澄清合併傳聞後,中信建投昨日再發公告稱,經本公司自查並書面詢證公司第一大股東北京國有資本經營管理中心及第二大股東中央匯金投資有限責任公司,截至本公告披露日,不存在應披露而未披露的重大信息。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.